bioLytical Laboratories: Not applicable (device, behavioral) study in HCV Infection (388 participants)
bioLytical Laboratories: Not applicable (device, behavioral) study in HCV Infection (388 participants). Its enrollment of 388 is above the median of 80 (86th percentile). Dated 6 days ago, it is inside the fresh trigger window. Score 85/100. As of 2026-11-04, from ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
enrollment: 388 · 86th percentile of 8,879 ClinicalTrialStartPulse records · 4.8x the median
Free preview: all 13 published fields of this record are shown below. Locked: 499 related ClinicalTrialStartPulse records and the 7-column CSV export.
| Field | Value |
|---|---|
| Sponsor | bioLytical Laboratories |
| Sponsor type | Industry (pharma, biotech, medtech) |
| Study | Clinical Study to Evaluate the Performance of the INSTI® HCV Antibody Test for CLIA-Waived Use |
| NCT ID | NCT07904416 |
| Phase | Not applicable (device, behavioral) |
| Status | not yet recruiting |
| Conditions | HCV Infection |
| Intervention types | diagnostic test |
| Target enrollment | 388 |
| Posted | 2026-10-29 |
| Planned start | 2026-11-01 |
| Event | Newly registered study |
| Event date | 2026-10-29 |
| enrollment percentile | 86th of 8,879 (median 80, 4.8x median) |
| Peer records CSV (500 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch bioLytical Laboratories
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Free first: a 10-record sample of records
See the real columns before you buy. One confirmation email, nothing else unless you opt in.
Unlock bioLytical Laboratories + 500 peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Phase · Conditions · Enrollment · Countries · Event · Posted · official source URL
- Source agency: ClinicalTrials.gov (U.S. National Library of Medicine) API v2
- Record date: 2026-10-29
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top ClinicalTrialStartPulse records (NONUS first): University of Oxford · DejthidaNathaphong · Eye & ENT Hospital of Fudan University · Shanghai First Maternal and Infant Health Hospital affiliate · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Browse all by state and category →
LIVE PUBLIC DATA Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 · Last refreshed: Wed, 04 Nov 2026 06:04:38 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: bioLytical Laboratories and 6,603 NONUS peers
- NONUS ClinicalTrialStartPulse records like this one: 6,603
- bioLytical Laboratories's enrollment: 86th percentile of 8,879 records
- Timing: High: dated in the last 7 days
- Estimated pipeline if you contact every NONUS peer: $1,320,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
85 / 100 Score
- Posted in the last two weeks.
- Industry sponsor (buys outsourced services).
- 388 participants planned.
- Not yet recruiting: vendors still being chosen.
What is the ClinicalTrialStartPulse record for bioLytical Laboratories?
bioLytical Laboratories registered a Not applicable (device, behavioral) study (NCT07904416) in HCV Infection targeting 388 participants, posted 2026-10-29.
How does bioLytical Laboratories compare to other ClinicalTrialStartPulse records?
Its enrollment of 388 sits in the upper half (86th percentile) of 8,879 records; the median is 80. It is fresh: dated 6 days ago, inside the window where early outreach matters most. Its Score of 85/100 puts it among the stronger signals in this feed.
bioLytical Laboratories vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| bioLytical Laboratories | NONUS | 388 | 86th | 2026-10-29 |
| Galderma R&D | NONUS | 326 | 84th | 2026-11-02 |
| Galderma R&D | NONUS | 162 | 72nd | 2026-11-03 |
| A.M.I. Agency for Medical Innovations GmbH | NONUS | 100 | 60th | 2026-10-30 |
Related records
ClinicalTrialStartPulse: Not applicable (device, behavioral) ClinicalTrialStartPulse: Outside the US only
How to monitor bioLytical Laboratories and peer not applicable (device, behavioral) records
Get new ClinicalTrialStartPulse records like bioLytical Laboratories by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.